Low Testosterone Level as a Predictor of Poststroke Emotional Disturbances: Anger Proneness and Emotional Incontinence

2018 ◽  
Vol 27 (12) ◽  
pp. 3549-3554 ◽  
Author(s):  
Mun Hee Choi ◽  
Tae Sung Lim ◽  
Bok Seon Yoon ◽  
Keoung Sun Son ◽  
Ji Man Hong ◽  
...  
Keyword(s):  
Testosterone Level ◽  
Emotional Disturbances ◽  
Low Testosterone

scholarly journals Normogonadotropic hypogonadism in men with obesity

2009 ◽  
Vol 6 (3) ◽  
pp. 39-42 ◽  
Author(s):  
L V Savel'eva ◽  
R V Rozhivanov ◽  
B O Shurdumova ◽  
V V Fadeev
Keyword(s):  
Testosterone Level ◽  
Healthy Subjects ◽  
Immunoreactive Insulin ◽  
Homa Index ◽  
Obese Patients ◽  
Functional Disorder ◽  
Testosterone Levels ◽  
Significant Difference ◽  
Low Testosterone ◽  
Index Calculation

Objective: to evaluate the preavalence and characteristics of hypogonadism in obese man. Research and Methods: Thestudy was performed in 31 obese man (aged 33 [22;44], BMI 40 [34,4;44,0]. Measurements during the study: chemistry panel, testosteroa and LH levels, immunoreactive insulin, HOMA index calculation. Statistically significant difference w as considered as p < 0,05. Results. Hypogonadism preavalence was 80,6%. The hypogonadism prevalence and testosterone level was more depended on age and obesity but less on duration. 100 % risk of hypogonadism w as observed in heavily obese patients. There w as no increase of LH levels. In man with low testosterone lev els HOMA index w as significantly higher со mpared to healthy subjects. Conclusion: The prevalence of normogonadotropic hypogonadism in obese men is extremely high and it represents an evidence of functional disorder of hypophyseal gonadal system. Thedecrease of testosterone levels is age-coinciding, but it is more pronounced in obese nan.

scholarly journals How to manage low testosterone level in men: a guide for primary care

2020 ◽  
Vol 70 (696) ◽  
pp. 364-365
Author(s):  
Ahmed Al-Sharefi ◽  
Scott Wilkes ◽  
Channa N Jayasena ◽  
Richard Quinton
Keyword(s):  
Primary Care ◽  
Testosterone Level ◽  
Low Testosterone

Low testosterone level in middle-aged male patients with coronary artery disease

2011 ◽  
Vol 22 (6) ◽  
pp. e133-e136 ◽  
Author(s):  
Xiaorong Hu ◽  
Li Rui ◽  
Tongjian Zhu ◽  
Hao Xia ◽  
Xinhong Yang ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Testosterone Level ◽  
Middle Aged ◽  
Male Patients ◽  
Low Testosterone ◽  
Artery Disease ◽  
Middle Aged Male

Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors

2010 ◽  
Vol 210 (1) ◽  
pp. 232-236 ◽  
Author(s):  
Masahiro Akishita ◽  
Masayoshi Hashimoto ◽  
Yumiko Ohike ◽  
Sumito Ogawa ◽  
Katsuya Iijima ◽  
...  
Keyword(s):  
Risk Factors ◽  
Testosterone Level ◽  
Cardiovascular Events ◽  
Coronary Risk Factors ◽  
Coronary Risk ◽  
Japanese Men ◽  
Low Testosterone

TESTOSTERONE AND METABOLIC SYNDROME IN MEN

2013 ◽  
pp. 5-14
Author(s):  
Hai Thuy Nguyen
Keyword(s):  
Metabolic Syndrome ◽  
Testosterone Level ◽  
Subsequent Development ◽  
Well Being ◽  
The Body ◽  
Testosterone Replacement Therapy ◽  
Aromatase Activity ◽  
Metabolic Markers ◽  
The Metabolic Syndrome ◽  
Low Testosterone

Testosterone is vital hormone for men’s health and a keyplayer in glucose homeostasis, lipid metabolism, and cardiovascular pathology. Testosterone deficiency is associated with age, many chronic health conditions and other metabolic disorders. There is strong evidence that a low testosterone level has a high prevalence in men with metabolic syndrome. Many components of metabolic syndrome are adversely affected especially in relation to cardiovascular risk in the presence of hypogonadism.Testosterone deficiency is a risk factor in itself for the subsequent development of the metabolic syndrome. The hypothesis suggests that low testosterone as a result of high aromatase activity leads to a cycle which promotes increasing adipocyte number and fat deposition which gradually leads to a lower testosterone level. The hypogonadal-obesity-adipocytokine hypothesis explains why the body cannot respond to low testosterone levels by a compensatory production of the hormone. The interventional studies have shown that testosterone administration on hypogonadal men with metabolic syndrome has beneficial effects. These benefits have not only found that hypogonadal symptoms such as sexual function improve, but key metabolic markers also improve. It must also not be forgotten that testosterone replacement therapy in hypogonadal men with metabolic syndrome can have a major impact on the patient’s quality of life and well-being. Key words: testosterone, metabolic syndrome.

Sign in / Sign up

Export Citation Format

Share Document